J.H. Meerwaldt

6.9k citations
41 papers · 1.9k indexed · h-index 21
Topics
Lymphoma Diagnosis and Treatment (15 papers)Breast Cancer Treatment Studies (8 papers)Lung Cancer Treatments and Mutations (8 papers)
Partner nations
NetherlandsFranceBelgium

In The Last Decade

J.H. Meerwaldt

40 papers receiving 1.8k citations

Peers

J.H. Meerwaldt
Comparison fields: 5 of 96
  • Pulmonary and Respiratory Medicine 885
  • Oncology 672
  • Pathology and Forensic Medicine 620
  • Surgery 422
  • Genetics 331
Replace Michel Schlienger with:
Michel Schlienger France
Naoto Shikama Japan
Giampaolo Biti Italy
Willem J. Klokman Netherlands
Bernard S. Aron United States
Barbara Fineberg United States
Daniel E. Dosoretz United States
John T. Chaffey United States
J. M. V. Burgers Netherlands
Robert H. Sagerman United States
J.H. Meerwaldt relative to Michel Schlienger France Michel Schlienger's profile →
Citations per field
00.5×1.5×1.9×
Michel Schlienger · 1×
Citations per year

Countries citing papers authored by J.H. Meerwaldt

Since Specialization
Citations

This map shows the geographic impact of J.H. Meerwaldt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.H. Meerwaldt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.H. Meerwaldt more than expected).

Fields of papers citing papers by J.H. Meerwaldt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.H. Meerwaldt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.H. Meerwaldt. The network helps show where J.H. Meerwaldt may publish in the future.

Co-authorship network of co-authors of J.H. Meerwaldt

This figure shows the co-authorship network connecting the top 25 collaborators of J.H. Meerwaldt. A scholar is included among the top collaborators of J.H. Meerwaldt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.H. Meerwaldt. J.H. Meerwaldt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 34
2 16
3 14
4 43
5 18
6 10
7 43
8 13
9
Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.
11
10 3
11 47
12 20
13 103
14 28
15 76
16 15
17 69
18 15
19 45
20 4

About J.H. Meerwaldt

J.H. Meerwaldt is a scholar working on Pathology and Forensic Medicine, Cancer Research and Radiation, having authored 41 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (15 papers), Breast Cancer Treatment Studies (8 papers) and Lung Cancer Treatments and Mutations (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (620 citations), Genetics (331 citations) and Pulmonary and Respiratory Medicine (885 citations). J.H. Meerwaldt has collaborated with scholars based in Netherlands, France and Belgium. Frequent co-authors include Job van der Palen, Jan J. Jobsen, András Vermes, Evert M. Noordijk, Henk‐Jan Guchelaar, Wim L.J. van Putten, Marnix L.M. Lybeert, Francisca Ong, Berthe M.P. Aleman and T. Girinsky. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026